Peng F. Guan

No.69, Increment Road
Wanghailou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Erratum to: Lycorine attenuates lipopolysaccharide-induced inflammation and intestinal epithelial barrier dysfunction in Caco-2 cells through inhibiting the STING/NF-κB pathway.

Erratum to: Lycorine attenuates lipopolysaccharide-induced inflammation and intestinal epithelial barrier dysfunction in Caco-2 cells through inhibiting the STING/NF-κB pathway.

Journal: Pakistan journal of pharmaceutical sciences

Published: July 18, 2025

Lycorine attenuates lipopolysaccharide-induced inflammation and intestinal epithelial barrier dysfunction in Caco-2 cells through inhibiting the STING/NF-κB pathway.

Lycorine attenuates lipopolysaccharide-induced inflammation and intestinal epithelial barrier dysfunction in Caco-2 cells through inhibiting the STING/NF-κB pathway.

Journal: Pakistan journal of pharmaceutical sciences

Published: February 09, 2025

Mechanistic study of Huangqi Guizhi Wuwu decoction amelioration of doxorubicin-induced cardiotoxicity by reducing oxidative stress and inhibiting cellular pyroptosis.

Mechanistic study of Huangqi Guizhi Wuwu decoction amelioration of doxorubicin-induced cardiotoxicity by reducing oxidative stress and inhibiting cellular pyroptosis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 18, 2023

Cyclovirobuxine D pretreatment ameliorates septic heart injury through mitigation of ferroptosis.

Cyclovirobuxine D pretreatment ameliorates septic heart injury through mitigation of ferroptosis.

Journal: Experimental and therapeutic medicine

Published: February 22, 2023

Isochronal superpositioning of the caged dynamics, the α, and the Johari-Goldstein β relaxations in metallic glasses.

Isochronal superpositioning of the caged dynamics, the α, and the Johari-Goldstein β relaxations in metallic glasses.

Journal: The Journal of chemical physics

Published: January 01, 2022

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis.

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis.

Journal: Frontiers in pharmacology

Published: November 10, 2021

Analysis of canopy phenology in man-made forests using near-earth remote sensing.

Analysis of canopy phenology in man-made forests using near-earth remote sensing.

Journal: Plant methods

Published: July 19, 2021

Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy.

Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy.

Journal: Frontiers in pharmacology

Published: February 19, 2021

Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling.

Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling.

Journal: Molecular and cellular biochemistry

Published: November 03, 2020

Resveratrol protects against CIH-induced myocardial injury by targeting Nrf2 and blocking NLRP3 inflammasome activation.

Resveratrol protects against CIH-induced myocardial injury by targeting Nrf2 and blocking NLRP3 inflammasome activation.

Journal: Life sciences

Published: November 25, 2019

Huperzine A, reduces brain iron overload and alleviates cognitive deficit in mice exposed to chronic intermittent hypoxia.

Huperzine A, reduces brain iron overload and alleviates cognitive deficit in mice exposed to chronic intermittent hypoxia.

Journal: Life sciences

Published: October 23, 2019

Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway.

Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway.

Journal: Life sciences

Published: May 02, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026